APA   Click to copy
DL, W., U, K., M, C., C, S., & R, S. (2022). Review: Sustainable Clinical Development of CAR-T Cells - Switching From Viral Transduction Towards CRISPR-Cas Gene Editing. Frontiers in Immunology, 13(June 17). https://doi.org/10.3389

Chicago/Turabian   Click to copy
DL, Wagner, Koehl U, Chmielewski M, Scheid C, and Stripecke R. “Review: Sustainable Clinical Development of CAR-T Cells - Switching From Viral Transduction Towards CRISPR-Cas Gene Editing.” Frontiers in Immunology 13, no. June 17 (2022).

MLA   Click to copy
DL, Wagner, et al. “Review: Sustainable Clinical Development of CAR-T Cells - Switching From Viral Transduction Towards CRISPR-Cas Gene Editing.” Frontiers in Immunology, vol. 13, no. June 17, PMID: 35784280; PMCID: PMC9248912, 2022, doi:10.3389.

@article{wagner2022a,
  title = {Review: Sustainable Clinical Development of CAR-T Cells - Switching From Viral Transduction Towards CRISPR-Cas Gene Editing},
  year = {2022},
  issue = {June 17},
  journal = {Frontiers in Immunology},
  volume = {13},
  doi = {10.3389},
  author = {DL, Wagner and U, Koehl and M, Chmielewski and C, Scheid and R, Stripecke},
  howpublished = {PMID: 35784280; PMCID: PMC9248912}
}